(Q45596801)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15330912%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Serum levels of hepatitis C virus core antigen as a marker of infection and response to therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15330912%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15330912%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Antonio Russo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15330912%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Roberta Soffredini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15330912%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Maria Luisa Parravicini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15330912%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Guido Ronchi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15330912%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Ersilio Del Ninno

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15330912%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Massimo Colombo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15330912%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

English

0 references

publication date

1 September 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15330912%20AND%20SRC:MED&resulttype=core&format=json

The American Journal of Gastroenterology

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15330912%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15330912%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15330912%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

1738-1743

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15330912%20AND%20SRC:MED&resulttype=core&format=json

Mucosal immunity and primary biliary cirrhosis: presence of antimitochondrial antibodies in urine

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30396.X

Total HCV core antigen assay: a new marker of hepatitis C viremia for monitoring the progress of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30396.X

Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30396.X

Comparative Evaluation of the Total Hepatitis C Virus Core Antigen, Branched-DNA, and Amplicor Monitor Assays in Determining Viremia for Patients with Chronic Hepatitis C during Interferon Plus Ribavirin Combination Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30396.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30396.X

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30396.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30396.X

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30396.X

Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30396.X

Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30396.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30396.X

Sequential serum hepatitis C viral RNA levels longitudinally assessed by branched DNA signal amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30396.X

Hepatitis C virus RNA profiles in chronically infected individuals: do they relate to disease activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30396.X

Use and interpretation of virological tests for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30396.X

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30396.X

Monitoring of viral levels during therapy of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30396.X

Standardized hepatitis C virus RNA panels for nucleic acid testing assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30396.X

Nonenveloped Nucleocapsids of Hepatitis C Virus in the Serum of Infected Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30396.X